TransEnterix to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
31 Enero 2018 - 5:55AM
Business Wire
TransEnterix, Inc. (NYSE American:TRXC) announced today that
Todd M. Pope, President and Chief Executive Officer, and Joseph P.
Slattery, Executive Vice President and Chief Financial Officer,
will present at the LEERINK Partners 7th Annual Global Healthcare
Conference at The Lotte New York Palace Hotel in New York, New
York. The presentation is scheduled to take place at 1:30 PM
Eastern, February 14, 2018.
A live audio webcast of the conference presentation will be
available online at the investor relations page of the Company’s
website at http://ir.transenterix.com/events.cfm. A replay of the
webcast will be archived on the website for approximately 90
days.
About TransEnterix
TransEnterix is a medical device company that is pioneering the
use of robotics to improve minimally invasive surgery by addressing
the clinical and economic challenges associated with current
laparoscopic and robotic options in today's value-based healthcare
environment. The company is focused on the commercialization of the
Senhance™ Surgical Robotic System, a multi-port robotic system that
brings the advantages of robotic surgery to patients while enabling
surgeons with innovative technology such as haptic feedback and eye
sensing camera control. The Senhance Surgical Robotic System is
available for sale in the US, the EU and select other countries.
For more information, visit the TransEnterix website at
www.transenterix.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180131005167/en/
TransEnterix, Inc.Investor Contact:Mark Klausner, +1
443-213-0501invest@transenterix.comorMedia Contact:Joanna
Rice, + 1 951-751-1858joanna@greymattermarketing.com
TransEnterix (AMEX:TRXC)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
TransEnterix (AMEX:TRXC)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024
Real-Time news about TransEnterix Inc New (American Stock Exchange): 0 recent articles
Más de Transenterix, Inc. Artículos de Noticias